Dynamic Technology Lab Private LTD Arbutus Biopharma Corp Transaction History

Dynamic Technology Lab Private LTD

  • $936 Million
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
SELL
$1.91 - $2.85 $9,343 - $13,942
-4,892 Reduced 26.41%
13,630 $32,000
Q3 2022

Nov 14, 2022
BUY
$1.88 - $2.88 $2,244 - $3,438
1,194 Added 6.89%
18,522 $35,000
Q2 2022

Aug 12, 2022
SELL
$1.98 - $3.17 $95,531 - $152,946
-48,248 Reduced 73.58%
17,328 $47,000
Q1 2022

May 16, 2022
BUY
$2.42 - $3.98 $158,693 - $260,992
65,576 New
65,576 $195,000

Others Institutions Holding ABUS

# of Institutions
130
Shares Held
82.2M
Call Options Held
4.82M
Put Options Held
546K
View Full List

About Arbutus Biopharma Corp

ABUS Quotes by TradingView
  • Ticker ABUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 149,951,008
  • Market Cap $510M
  • Description
  • Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...
More about ABUS
Track This Portfolio

Track Dynamic Technology Lab Private LTD Portfolio

Follow Dynamic Technology Lab Private LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

News

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email